| PERIOD ENDING | 30-Aug-09 | 31-May-09 | 1-Mar-09 | 30-Nov-08 | | Total Revenue | 60,943 | 52,237 | 53,911 | 58,037 | | Cost of Revenue | 52,073 | 43,228 | 46,320 | 50,480 | | | Gross Profit | 8,870 | 9,009 | 7,591 | 7,557 | | | Operating Expenses | | Research Development | 939 | 1,018 | 891 | 868 | | Selling General and Administrative | 4,570 | 4,739 | 4,153 | 4,449 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,361 | 3,252 | 2,547 | 2,240 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 288 | 274 | 220 | 455 | | Earnings Before Interest And Taxes | 3,649 | 3,377 | 2,657 | 2,563 | | Interest Expense | 1 | 2 | 2 | 2 | | Income Before Tax | 3,648 | 3,375 | 2,655 | 2,561 | | Income Tax Expense | 1,282 | 1,522 | 1,115 | 1,063 | | Minority Interest | (182) | (149) | (110) | (132) | | | | Net Income From Continuing Ops | 2,184 | 1,853 | 1,540 | 1,498 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,184 | 1,853 | 1,540 | 1,498 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,184 | $1,853 | $1,540 | $1,498 |
|
1.48% Nasdaq 0.00%
Income Statement
